Search Results
Apr 28, 2026, 08:00 ET Trinity Capital Inc. Provides $30 Million in Growth Capital to Iantrek to Accelerate Commercial Expansion and Advance Product Pipeline
Iantrek, a medical technology company and a leader in the bio-interventional ophthalmic surgery (BIOS) space.
More news about: Trinity Capital Inc.
Apr 28, 2026, 07:00 ET Transpire Bio Announces Opening of New Satellite R&D Facility in Shanghai, China
regions, further expanding our ability to innovate and bring new therapeutic options to patients around the world."This strengthens Transpire Bio's ability to serve global markets, with the Shanghai facility maintaining a special focus on developing complex generic inhalation products for the EU/UK
More news about: Transpire Bio
Apr 23, 2026, 16:05 ET Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model
wholly owned biomanufacturing subsidiary.A Differentiated Asset at the Intersection of National Preparedness and OncologyValion Bio's lead drug candidate, Entolimod™, is a novel Toll-like receptor 5 (TLR5) agonist with a differentiated, dual-utility profile. As a medical countermeasure
More news about: Tivic Health Systems, Inc.
Apr 23, 2026, 13:59 ET Functional Medicine Founder Who Built a $12M Company From a Laptop Named Inaugural Gold Stevie® Award Winner for Best Female Entrepreneur
SearchFunctionalMedicine.com actively supports practitioners' online presence — providing SEO-optimized backlinks to their websites, up to 2,000-word practitioner bios, and the ability to list certifications and training from any institution. Patients can filter by geographic area, in-person or virtual availability,
More news about: The Dr Z Functional Medicine Academy, LLC
Apr 21, 2026, 14:55 ET AMI Firmware Validated for Arm AGI CPU Platforms, Accelerating Infrastructure Deployment
Aptio® V UEFI/BIOS Firmware and
More news about: AMI
Apr 20, 2026, 16:05 ET Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026
conference call, participants can dial +1 833-461-5787 (U.S. toll-free) and enter access code 266802059. An archived recording will be available on Nuvation Bio's website for 90 days following the event.About Nuvation Bio Nuvation Bio is a global oncology company focused on tackling some
More news about: Nuvation Bio Inc.
Apr 20, 2026, 08:00 ET Deck Bio Presents Preclinical Data on DBXO-1, a Multi-pMHC Targeted T Cell Engager, at AACR 2026
The data highlight Deck Bio's strategy to overcome key limitations of T cell engagers in solid tumors, including low antigen density, tumor heterogeneity, and the scarcity of tumor-specific
More news about: Deck Bio, Inc.
Apr 20, 2026, 07:30 ET TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region
and TJ Biopharma ("TJ Bio") today announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bio's exclusive rights to felzartamab in the Greater China Region. With this agreement, Biogen now owns exclusive worldwide rights to felzartamab, which is
More news about: TJ Biopharma
Apr 16, 2026, 14:25 ET How IBM Quantum is Enabling Healthcare and Biology Research
demanding problems at the intersection of quantum information science and real-world use cases.Below, we highlight the work carried out by Q4Bio's Phase III finalists on IBM quantum hardware. Their projects offer an exciting glimpse at how quantum computing is beginning to support meaningful research
More news about: IBM
Apr 16, 2026, 10:46 ET Fresha Launches Searchable Professional Profiles, Redefining Discovery in Beauty and Wellness Across the Global Selfcare Economy
extensive, content-rich portfolios that cover everything from ratings and verified client reviews to services offered, real-time availability, images, bios, languages spoken, qualifications, and areas of expertise all of which are searchable allowing clients and stylists to intelligently match to their perfect
More news about: Fresha
Apr 16, 2026, 08:00 ET Panome Bio and Audubon Bioscience Partner to Deliver End-to-End FFPE Biospecimen and Metabolomics Solutions for Cancer Researchers
Center, April 17–22, 2026. Researchers interested in learning more about TissueBridge™ FFPE Metabolomics, the Audubon Bioscience partnership, or Panome Bio's full suite of multi-omic services are encouraged to visit Booth #2015 or contact the team at [email protected]
More news about: Panome Bio
Apr 15, 2026, 12:03 ET Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab
injection), a PCSK9 program approved in China for the treatment of adult patients with primary hypercholesterolemia and mixed dyslipidemia.IASO Bio's FUCASO® (equecabtagene autoleucel), a BCMA CAR-T program approved in China for the treatment of patients with multiple myeloma.Invivyd's
More news about: Adimab, LLC
Apr 15, 2026, 11:12 ET /C O R R E C T I O N -- Artsy and Artnet/
www.artnet.com.Bios:Andrew Wolff, founder and CEO of Beowolff CapitalAndrew Wolff is the CEO of Beowolff Capital, which he founded in 2022.
More news about: Artsy and Artnet
Apr 15, 2026, 10:00 ET Clicklinks | 14-Day Candidate Antibody Discovery - Sanyou AI-STAL 2.0 Defines the Era of Ultimate Speed in Drug Molecule Discovery
binding to the overexpressing cell line.05 Summary and OutlookSanyou Bio's 14-Day Candidate Antibody Discovery Workflow is a deep practice of the "intelligent R&D" concept, marking the entry of Sanyou Bio's drug R&D into a new stage of "high speed, high throughput, and high certainty".
More news about: Sanyou Bio
Apr 14, 2026, 06:00 ET The Public Voices Fellowship on Youth Well-being and Power Announces 2026 Fellows
here to see their bios):Jorge Alvarez is a nationally recognized mental health advocate, social impact strategist, and creator redefining how young people lead
More news about: Hopelab
Apr 13, 2026, 22:25 ET THE ROCK & ROLL HALL OF FAME REVEALS 2026 INDUCTEES
rockhall.com/membership to learn more.Press can access hi-resolution images and bios for the 2026 Inductees at
More news about: Rock and Roll Hall of Fame
Apr 13, 2026, 21:53 ET THE ROCK & ROLL HALL OF FAME REVEALS 2026 INDUCTEES
rockhall.com/membership to learn more.Press can access hi-resolution images and bios for the 2026 Inductees at
More news about: Rock and Roll Hall of Fame
Apr 10, 2026, 09:55 ET Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
massive production scale required for commercially-viable islet cell therapy in Type 1 Diabetes — a program that runs thematically parallel to Avaí Bio's own diabetes and anti-aging efforts through encapsulated cells. Lineage also achieved a first milestone under its worldwide collaboration with Roche's
More news about: USA News Group
Apr 10, 2026, 09:31 ET IASO Bio Establishes International Partnership with Instituto Butantan to Develop Innovative Therapy for Hematological Cancer
possibilities for patients who no longer respond to conventional therapies," he says."This partnership with Butantan is a pivotal milestone in IASO Bio's global strategy to bring our innovative cell therapies to patients in Latin America," said Jinhua Zhang, Founder, Chairwoman and CEO of IASO Bio. "By
More news about: IASO Bio
Apr 09, 2026, 08:00 ET Deck Bio Launches Multi-Target T Cell Engager Platform for Solid Tumors, With Preclinical Data to be Presented at AACR 2026
immuno-oncology approaches and expand the impact of immunotherapy in solid tumors. Preclinical data will be presented by Johanna Kaufmann, Ph.D., Deck Bio's Chief Scientific Officer, at the upcoming
More news about: Deck Bio, Inc.
Apr 09, 2026, 07:00 ET AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
ROC-101 was found to be safe, well tolerated, and showed no evidence of hypotension.About ROCSTARThe ROCSTAR trial is AllRock Bio's Phase 2a open-label, multicenter, exploratory clinical study investigating its lead asset, ROC-101. The trial will evaluate the safety, tolerability,
More news about: AllRock Bio
Apr 08, 2026, 07:50 ET ENT Specialists, Inc. Opens New Dedham Office, 60 Years of World Class ENT Care to Massachusetts
Specialists accepts most major insurance plans and welcomes both new and established patients.Note to Editors: High-resolution images and physician bios are available upon request.MEDIA CONTACTGreg Gonser | Saltbox Marketing617-416-8262
More news about: ENT Specialists, Inc.
Apr 08, 2026, 06:59 ET Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference
25th Annual Needham Virtual Healthcare Conference.A webcast of the presentation will be available on the Events and Presentations page of Q32 Bio's website at
More news about: Q32 Bio
Apr 08, 2026, 04:00 ET Ribbon Bio Appoints Dr. Urs Spitz as Chair of the Board
critical raw materials, culminating in a successful 2022 exit to KKR Speaking on his appointment, Spitz said: "I am fascinated by Ribbon Bio's ambition to provide reliable and quick access to complex, cell-free DNA to accelerate the next wave of breakthroughs in biotechnology. The company has
More news about: Ribbon Bio
Apr 07, 2026, 08:00 ET Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology
settings. The addition of Surf Bio's polymer‑based hyperconcentration technology further broadens the range of biologics that can be delivered subcutaneously, meaningfully expanding the scope of opportunities across therapeutic modalities. Together, Hypercon™ and Surf Bio's technology complement ENHANZE®
More news about: Halozyme Therapeutics, Inc.